InvestorsHub Logo

misiu143

09/03/21 6:38 PM

#182180 RE: B52T38 #182172

B52T38 - i believe it is to soon to predict how those things are possible or not with vaccine .. or with anything really ..

Japan study showed that the spike protein in vaccine not staying in deltoid muscles in the arm , but circulating through our body ..with it also circulating lipid nanoparticles in the mRNA vaccines , and cumulate in different organs ..

Spike protein produce inflammation in the endothelium of blood vessels through the body .,

I don’t think anyone knows , for how long this will be happening .. weeks , months ??

And we do see some problems , we see small number , especially young , and more often male developing myocarditis , pericarditis , we see immune thrombocytopenia and we see blood clots in between other..

But those are to what we hearing not a very common occurrences ..

I very strongly believe that because of MOA , if Leronlimab will be given with vaccine , or later if complication happens , it will at least help if not prevent these problems , including blood clots ..same as in covid ..

We know now that platelets are part of our immune system , and we have platelets derive cytokines and they are regulated by CCL5 ( Rantes ) .,

But all this will need to be proven by different studies , and tests ,
many things were observed during our COVID , LH and NASH studies , and Dr Recknor commented , I think during our last CC , that he is coming with many interesting biometers which will be proving many things ..

So we need to have some more patience , I think very interesting information is coming about our Leronlimab..

I hope that others will correct me or add if needed ..

Thank you..

And all imo ..